Medical Decision Modeling Inc., Indianapolis, IN 46268, USA.
Health Serv Res. 2013 Aug;48(4):1508-25. doi: 10.1111/1475-6773.12044. Epub 2013 Feb 13.
To identify the problem of separating statistical noise from treatment effects in health outcomes modeling and analysis. To demonstrate the implementation of one technique, common random numbers (CRNs), and to illustrate the value of CRNs to assess costs and outcomes under uncertainty.
A microsimulation model was designed to evaluate osteoporosis treatment, estimating cost and utility measures for patient cohorts at high risk of osteoporosis-related fractures. Incremental cost-effectiveness ratios (ICERs) were estimated using a full implementation of CRNs, a partial implementation of CRNs, and no CRNs. A modification to traditional probabilistic sensitivity analysis (PSA) was used to determine how variance reduction can impact a decision maker's view of treatment efficacy and costs.
The full use of CRNs provided a 93.6 percent reduction in variance compared to simulations not using the technique. The use of partial CRNs provided a 5.6 percent reduction. The PSA results using full CRNs demonstrated a substantially tighter range of cost-benefit outcomes for teriparatide usage than the cost-benefits generated without the technique.
CRNs provide substantial variance reduction for cost-effectiveness studies. By reducing variability not associated with the treatment being evaluated, CRNs provide a better understanding of treatment effects and risks.
确定在健康结果建模和分析中从统计学噪声中分离治疗效果的问题。展示一种技术(常用随机数)的实现,并说明其在评估不确定性下的成本和结果方面的价值。
设计了一个微观模拟模型来评估骨质疏松症的治疗效果,估算了高骨质疏松性骨折风险患者群体的成本和效用指标。使用常用随机数的完全实现、部分实现和不使用常用随机数的方法来估计增量成本效果比(ICER)。使用传统概率敏感性分析(PSA)的修改来确定方差减少如何影响决策者对治疗效果和成本的看法。
与不使用该技术的模拟相比,完全使用常用随机数可将方差降低 93.6%。部分使用常用随机数可将方差降低 5.6%。使用完全常用随机数的 PSA 结果表明,特立帕肽使用的成本效益结果范围比不使用该技术的成本效益结果范围要紧密得多。
常用随机数为成本效益研究提供了大量的方差减少。通过减少与所评估治疗无关的变异性,常用随机数提供了对治疗效果和风险的更好理解。